copper-64-DOTA-NR-LU-10

Known as: 64Cu-DOTA-NR-LU-10 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2001
02419902001

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
AIM AND BACKGROUND Radioimmunoguided surgery using radiolabeled NR-LU-10 Fab was evaluated as a method of intraoperative breast… (More)
Is this relevant?
1999
1999
A mouse-human chimeric monoclonal antibody (chNR-LU-13), specific for the EGP40 pancarcinoma antigen, was humanized through three… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 5
Is this relevant?
1997
1997
BACKGROUND Previous studies suggest that the radiobiologic characteristics of in vitro survival curves are important determinants… (More)
Is this relevant?
1996
1996
Low tumor uptake and normal tissue toxicity limit the efficacy of RIT for the treatment of solid tumors. In this study, an… (More)
Is this relevant?
1993
1993
Local hyperthermia and the hypoxic cytotoxin SR 4233 were administered to nude mice with 693 +/- 47 mm3 (mean +/- SE) s.c. HCT-8… (More)
  • figure I
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
1993
Review
1993
Radiolabeled antibodies have been studied by several investigators as to their potential role in the diagnosis and staging of… (More)
Is this relevant?
1993
1993
The Neoprobe Model 1000 hand-held gamma detector, in combination with the murine monoclonal antibody (MAb) B72.3 can successfully… (More)
Is this relevant?
1993
1993
UNLABELLED Computed tomographic scanning has improved the noninvasive staging of lung cancer but has the deficiency of not… (More)
Is this relevant?
1991
1991
A 186Re-labeled monoclonal antibody (MAb), NR-LU-10, was used for the radioimmunotherapy of a subcutaneous human small cell lung… (More)
Is this relevant?
1990
1990
Biodistribution, pharmacokinetic, and radioimaging studies were performed with 186Re-labeled NR-LU-10 whole antibody in athymic… (More)
  • figure I
  • table 1
  • table 2
  • figure 4
  • figure 5
Is this relevant?